The biosimilar market is growing with incredible momentum

In an interview with 4investors, Enno Spillner, CFO of Formycon AG, talks about the rapidly growing biosimilar market, Formycon’s 2025/2029 bond, and how the proceeds will fuel Formycon’s further growth.

You can read the full interview here:

Formycon: „Biosimilar-Markt wächst mit beeindruckender Dynamik“ | 4investors